FDA pushes back deadline on NPS app; Sanofi's R&D shift incites opposition in France; MEI acquires S*BIO drug rights;

 @FierceBiotech: FDA taps data-mining tech for drug safety research. More | Follow @FierceBiotech

 @JohnCFierce: Elcelyx sheds stealth status, adds venture bucks as it seeks obesity pacts. More | Follow @JohnCFierce

 @RyanMFierce: Mount Sinai's Eric Schadt reflects on first year at $100 million genomics center. More | Follow @RyanMFierce

> The FDA has extended its deadline for a decision on NPS Pharmaceuticals' NDA for Gattex, a treatment for short bowel syndrome. The new PDUFA date is December 30, 2012. Release

> Sanofi ($SNY) isn't making many friends in France as it shifts its R&D presence more towards Cambridge, MA. Story

> MEI Pharma is acquiring S*BIO's rights to Pracinostat, an oral histone deacetylase (HDAC) inhibitor. Release

Pharma News

 @FiercePharma: "Unnerved" by "weakness in the base business," Jefferies downgrades Glaxo to "hold." Next year = better, firm says. More | Follow @FiercePharma

> NICE stiff-arms Roche melanoma drug once again. News

> Sun finally nabs Taro with $600M deal. News

> Icahn accuses Forest of hidden 'poison pill.' More

> It's official: Pfizer files its animal-health IPO. Report

Medical Device News

 @FierceMedDev: Given Imaging's rough stock slump last week was a major overreaction, at least one analyst is saying--via Bloomberg. More | Follow @FierceMedDev

 @MarkHFierce: MIT tech helped U.K. scientists discover a new class of polymers that could coat med devices and help reduce bacteria. Story | Follow @MarkHFierce

 @DamianFierce: Medtronic is looking to get a foothold in China with some M&A. More | Follow @DamianFierce

> U.K. researchers wield MIT tech to discover new class of antimicrobial polymers. Item

> FDA clears Stryker's next-gen stroke treatment device. News

Biotech IT News

> BioClinica accelerates spending to support eClinical surge. Article

> Sanofi trains social-media eye on diabetics. Story

> U.K. scientists tap into e-health research with Centers of Excellence. More

CRO News

> Theorem and Gallus team up to offer CRO, CMO services. Article

> Charles River bolsters IT spending to stand out in CRO crowd. Story

> Fuji Pharma jumps into CMO game with $53.4M plant buy. More

And Finally… Another study has concluded that a daily dose of aspirin can reduce the risk of dying from cancer. Story

 

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.